Literature DB >> 8941198

Self-poisoning among adults using multiple transdermal nicotine patches.

A Woolf1, K Burkhart, T Caraccio, T Litovitz.   

Abstract

OBJECTIVE: To investigate the characteristics and outcomes of poisoning cases involving the dermal application of multiple transdermal nicotine patches.
DESIGN: Case series; prospective postmarketing surveillance over a 24 month period.
SETTING: Telephone reports from 34 participating US poison centers. PATIENTS: Human poisonings involving more than one transdermal nicotine patch applied simultaneously.
RESULTS: Nine cases of dermal exposure to 2-20 transdermal nicotine patches were reported. Cases resulted from either intentional misuse or suicide attempts and included concomitant exposure to other drugs in 7 of 9 cases. Mean age was 45 years; seven of nine patients were female. All suffered medical complications including seizures (3 subjects), other central nervous system changes (8 subjects), cardiovascular effects (6 subjects), and respiratory failure (4 subjects). Eight patients were hospitalized; all recovered. Plasma nicotine/cotinine concentrations did not correlate with the severity of illness.
CONCLUSIONS: This case series demonstrated that simultaneous application of several transdermal nicotine patches can be implicated in adult suicide attempts. While signs of toxicity included gastrointestinal complaints, changes in level of consciousness, seizures and parasympathetic effects typical of nicotine poisoning, the frequent presence of co-intoxicants complicated the clinical course. As the accessibility of transdermal nicotine patches increases, increasing misuse of these products by suicidal adults is likely.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941198     DOI: 10.3109/15563659609013830

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  13 in total

1.  Reporting of adverse drug reactions by poison control centres in the US.

Authors:  P A Chyka; S W McCommon
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

2.  Estimating the health consequences of replacing cigarettes with nicotine inhalers.

Authors:  W Sumner
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

Review 3.  Smoking and suicide: a brief overview.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-08-03       Impact factor: 4.492

4.  Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.

Authors:  A Kuryatov; V Gerzanich; M Nelson; F Olale; J Lindstrom
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

5.  Not only smoking is deadly: fatal ingestion of e-juice-a case report.

Authors:  Svenja Bartschat; Katja Mercer-Chalmers-Bender; Justus Beike; Markus A Rothschild; Martin Jübner
Journal:  Int J Legal Med       Date:  2014-09-20       Impact factor: 2.686

Review 6.  Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells.

Authors:  Lorise C Gahring; Scott W Rogers
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

Review 7.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 8.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

9.  Symptomatic bradycardia due to nicotine intoxication.

Authors:  Jin Hui Paik; Soo Kang; Areum Durey; Ji Hye Kim; Ah Jin Kim
Journal:  Rev Bras Ter Intensiva       Date:  2018-03

10.  Permissive nicotine regulation as a complement to traditional tobacco control.

Authors:  Walton Sumner
Journal:  BMC Public Health       Date:  2005-02-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.